메뉴 건너뛰기




Volumn 16, Issue 4, 2009, Pages 29-34

Comorbid cannabis misuse in psychotic disorders: Treatment strategies

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; BUSPIRONE; CLOZAPINE; DRONABINOL; NALTREXONE; NEFAZODONE; OLANZAPINE; RIMONABANT;

EID: 76749169788     PISSN: 10826319     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (4)

References (66)
  • 1
    • 76749153676 scopus 로고    scopus 로고
    • Global Illicit Drug Trends 2002. New York, NY: United Nations Office for Drug Control and Crime Prevention; 2002.
    • Global Illicit Drug Trends 2002. New York, NY: United Nations Office for Drug Control and Crime Prevention; 2002.
  • 2
    • 0030761521 scopus 로고    scopus 로고
    • Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu-1 opioid receptor mechanism
    • Tanda G, Pontieri FE, Di Chiara G. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu-1 opioid receptor mechanism. Science. 1997;276(5321):2048-2050.
    • (1997) Science , vol.276 , Issue.5321 , pp. 2048-2050
    • Tanda, G.1    Pontieri, F.E.2    Di Chiara, G.3
  • 4
    • 39649085680 scopus 로고    scopus 로고
    • Cannabis use and risk of lung cancer: A case-controlled study
    • Aldington S, Harwood M, Cox B, et al. Cannabis use and risk of lung cancer: a case-controlled study. Eur Respir J. 2008;31(2):280-286.
    • (2008) Eur Respir J , vol.31 , Issue.2 , pp. 280-286
    • Aldington, S.1    Harwood, M.2    Cox, B.3
  • 5
    • 0442307621 scopus 로고    scopus 로고
    • Causal association between cannabis and psychosis: Examination of the evidence
    • Arseneault L, Cannon M, Witton J, Murray RM. Causal association between cannabis and psychosis: examination of the evidence. Br J Psychiatry. 2004;84:110-117.
    • (2004) Br J Psychiatry , vol.84 , pp. 110-117
    • Arseneault, L.1    Cannon, M.2    Witton, J.3    Murray, R.M.4
  • 6
    • 76749115530 scopus 로고    scopus 로고
    • SAMHSA. Office of Applied Studies. The NSDUH Report: Age at First Use of Marijuana and Past Year Serious Mental Illness. Available at: http://oas.samhsa.gov/2k5/MJageSMI/MJageSMI.cfm. Accessed February 26, 2009.
    • SAMHSA. Office of Applied Studies. The NSDUH Report: Age at First Use of Marijuana and Past Year Serious Mental Illness. Available at: http://oas.samhsa.gov/2k5/MJageSMI/MJageSMI.cfm. Accessed February 26, 2009.
  • 8
    • 0025106132 scopus 로고
    • Epidemiological analysis of alcohol and drug use as risk factors for psychotic experiences
    • Tien AY, Anthony JC. Epidemiological analysis of alcohol and drug use as risk factors for psychotic experiences. J Nerv Ment Dis. 1990;178(8):473-480.
    • (1990) J Nerv Ment Dis , vol.178 , Issue.8 , pp. 473-480
    • Tien, A.Y.1    Anthony, J.C.2
  • 10
    • 0030972351 scopus 로고    scopus 로고
    • Towards a cannabinoid hypothesis of schizophrenia: Cognitive impairment due to dysregulation of the endogenous cannabinoid system
    • Emrich HM, Leweke FM, Schneider U. Towards a cannabinoid hypothesis of schizophrenia: cognitive impairment due to dysregulation of the endogenous cannabinoid system. Pharmacol Biochem Behav. 1997;56(4):803-807.
    • (1997) Pharmacol Biochem Behav , vol.56 , Issue.4 , pp. 803-807
    • Emrich, H.M.1    Leweke, F.M.2    Schneider, U.3
  • 11
    • 0029955156 scopus 로고    scopus 로고
    • Cannabis use correlates with schizotypy in healthy people
    • Williams JH, Wellman NA, Rawlins JN. Cannabis use correlates with schizotypy in healthy people. Addiction. 1996;91(6):869-877.
    • (1996) Addiction , vol.91 , Issue.6 , pp. 869-877
    • Williams, J.H.1    Wellman, N.A.2    Rawlins, J.N.3
  • 12
    • 0030030990 scopus 로고    scopus 로고
    • A longitudinal study of drug and alcohol use by psychosis-prone and impulsive-nonconforming individuals
    • Kwapil TR. A longitudinal study of drug and alcohol use by psychosis-prone and impulsive-nonconforming individuals. J Abnorm Psychol. 1996;105(1):114-123.
    • (1996) J Abnorm Psychol , vol.105 , Issue.1 , pp. 114-123
    • Kwapil, T.R.1
  • 13
    • 0035280534 scopus 로고    scopus 로고
    • Cannabis use is associated with schizotypy and attentional disinhibition
    • Skosnick PD, Spatz-Glen L, Parks S. Cannabis use is associated with schizotypy and attentional disinhibition. Schizophr Res. 2001;48(1):83-92.
    • (2001) Schizophr Res , vol.48 , Issue.1 , pp. 83-92
    • Skosnick, P.D.1    Spatz-Glen, L.2    Parks, S.3
  • 14
    • 0035178555 scopus 로고    scopus 로고
    • The incidence of schizotypy among cannabis and alcohol users
    • Nunn J, Rizza F, Peters ER. The incidence of schizotypy among cannabis and alcohol users. J Nerv Ment Dis. 2001;189(11):741-748.
    • (2001) J Nerv Ment Dis , vol.189 , Issue.11 , pp. 741-748
    • Nunn, J.1    Rizza, F.2    Peters, E.R.3
  • 15
    • 0037210039 scopus 로고    scopus 로고
    • Cannabis and dimensions of psychosis in a non-clinical population of female students
    • Verdoux H, Sorbara F, Gindre C, Swenden D, van Os J. Cannabis and dimensions of psychosis in a non-clinical population of female students. Schizophr Res. 2003;59(1):77-84.
    • (2003) Schizophr Res , vol.59 , Issue.1 , pp. 77-84
    • Verdoux, H.1    Sorbara, F.2    Gindre, C.3    Swenden, D.4    van Os, J.5
  • 16
    • 0035136656 scopus 로고    scopus 로고
    • Psychiatric effects of cannabis
    • Johns A. Psychiatric effects of cannabis. Br J Psychiatry. 2001;178:116-122.
    • (2001) Br J Psychiatry , vol.178 , pp. 116-122
    • Johns, A.1
  • 17
    • 0035822323 scopus 로고    scopus 로고
    • Cannabinoids for control of chemotherapy induced nausea and vomiting: Quantitative systematic review
    • Tramèr MR, Carroll D, Campbell FA, Reynolds DJ, Moore RA, McQuay HJ. Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review. BMJ. 2001;323(7303):16-21.
    • (2001) BMJ , vol.323 , Issue.7303 , pp. 16-21
    • Tramèr, M.R.1    Carroll, D.2    Campbell, F.A.3    Reynolds, D.J.4    Moore, R.A.5    McQuay, H.J.6
  • 18
    • 0037237704 scopus 로고    scopus 로고
    • Effects of cannabis use and psychosis vulnerability in daily life: An experience sampling test study
    • Verdoux H, Gindre C, Sorbara F, Tournier M, Swendsen J. Effects of cannabis use and psychosis vulnerability in daily life: an experience sampling test study. Psychol Med. 2003;33(1):23-32.
    • (2003) Psychol Med , vol.33 , Issue.1 , pp. 23-32
    • Verdoux, H.1    Gindre, C.2    Sorbara, F.3    Tournier, M.4    Swendsen, J.5
  • 19
    • 0035138027 scopus 로고    scopus 로고
    • Pharmacology and effects of cannabis: A brief review
    • Ashton C. Pharmacology and effects of cannabis: a brief review. Br J Psychiatry. 2001;178:101-106.
    • (2001) Br J Psychiatry , vol.178 , pp. 101-106
    • Ashton, C.1
  • 20
    • 0442273080 scopus 로고    scopus 로고
    • Is there a specific "cannabis psychosis"?
    • Murray R, Castle D, eds, New York, NY: Cambrige University Press;
    • Hall W, Degenhardt L. Is there a specific "cannabis psychosis"? In: Murray R, Castle D, eds. Marijuana and Madness. New York, NY: Cambrige University Press; 2004:89-100.
    • (2004) Marijuana and Madness , pp. 89-100
    • Hall, W.1    Degenhardt, L.2
  • 22
    • 0034583110 scopus 로고    scopus 로고
    • Cannabis use and psychosis: A review of clinical and epidemiological evidence
    • Hall W, Degenhardt L. Cannabis use and psychosis: a review of clinical and epidemiological evidence. Aust N Z J Psychiatry. 2000;34(1):26-34.
    • (2000) Aust N Z J Psychiatry , vol.34 , Issue.1 , pp. 26-34
    • Hall, W.1    Degenhardt, L.2
  • 23
    • 0037103169 scopus 로고    scopus 로고
    • Cannabis use and psychosis: A longitudinal population-based study
    • Van Os J, Bak M, Bijl RV, De Graaf R, Verdoux H. Cannabis use and psychosis: a longitudinal population-based study. Am J Epidemiol. 2002;156(4):319-327.
    • (2002) Am J Epidemiol , vol.156 , Issue.4 , pp. 319-327
    • Van Os, J.1    Bak, M.2    Bijl, R.V.3    De Graaf, R.4    Verdoux, H.5
  • 24
    • 0025809884 scopus 로고
    • What is a cause and how do we know one? A grammar for pragmatic epidemiology
    • Susser M. What is a cause and how do we know one? A grammar for pragmatic epidemiology. Am J Epidemiol. 1991;133(7):635-648.
    • (1991) Am J Epidemiol , vol.133 , Issue.7 , pp. 635-648
    • Susser, M.1
  • 25
    • 0000735519 scopus 로고
    • Cannabis and schizophrenia: A longitudinal study of Swedish conscripts
    • Andreasson S, Allebeck P, Engstrom A, Rydberg U. Cannabis and schizophrenia: a longitudinal study of Swedish conscripts. Lancet. 1987;2(8574):1483-1485.
    • (1987) Lancet , vol.2 , Issue.8574 , pp. 1483-1485
    • Andreasson, S.1    Allebeck, P.2    Engstrom, A.3    Rydberg, U.4
  • 26
    • 0037164374 scopus 로고    scopus 로고
    • Self-reported cannabis use as a risk factor for schizophrenia: Further analysis of the 1969 Swedish conscript cohort
    • Zammit S, Allebeck P, Andreasson S, Lundberg I, Lewis G. Self-reported cannabis use as a risk factor for schizophrenia: further analysis of the 1969 Swedish conscript cohort. BMJ. 2002;325(7374):1199-1201.
    • (2002) BMJ , vol.325 , Issue.7374 , pp. 1199-1201
    • Zammit, S.1    Allebeck, P.2    Andreasson, S.3    Lundberg, I.4    Lewis, G.5
  • 27
    • 0037164390 scopus 로고    scopus 로고
    • Cannabis use in adolescence and risk for adult psychosis: Longitudinal prospective study
    • Arseneault L, Cannon M, Poulton R, Murray R, Caspi A, Moffitt TE. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ. 2002;325(7374):1212-1213.
    • (2002) BMJ , vol.325 , Issue.7374 , pp. 1212-1213
    • Arseneault, L.1    Cannon, M.2    Poulton, R.3    Murray, R.4    Caspi, A.5    Moffitt, T.E.6
  • 29
    • 3042752521 scopus 로고    scopus 로고
    • Adolescent exposure to cannabinoids induces long-lasting changes in the response to drugs of abuse in rat midbrain dopamine neurons
    • Pistis M, Perra S, Pillolla G, Melis M, Muntoni AL, Gessa GL. Adolescent exposure to cannabinoids induces long-lasting changes in the response to drugs of abuse in rat midbrain dopamine neurons. Biol Psychiatry. 2004;56(2):86-94.
    • (2004) Biol Psychiatry , vol.56 , Issue.2 , pp. 86-94
    • Pistis, M.1    Perra, S.2    Pillolla, G.3    Melis, M.4    Muntoni, A.L.5    Gessa, G.L.6
  • 30
    • 43749124806 scopus 로고    scopus 로고
    • Puberty as a highly vulnerable developmental period for the consequences of cannabis exposure
    • Schneider, M. Puberty as a highly vulnerable developmental period for the consequences of cannabis exposure. Addict Biol. 2008;13(2):253-263.
    • (2008) Addict Biol , vol.13 , Issue.2 , pp. 253-263
    • Schneider, M.1
  • 31
    • 55449108707 scopus 로고    scopus 로고
    • A cannabinoid analogue of delta(9)-tetrahydrocannabinol disrupts neural development in chick
    • Psychoyos D, Hungund B, Cooper T, Finnell RH. A cannabinoid analogue of delta(9)-tetrahydrocannabinol disrupts neural development in chick. Birth Defects Res B Dev Reprod Toxicol. 2008;83(5):477-488.
    • (2008) Birth Defects Res B Dev Reprod Toxicol , vol.83 , Issue.5 , pp. 477-488
    • Psychoyos, D.1    Hungund, B.2    Cooper, T.3    Finnell, R.H.4
  • 32
    • 17744379225 scopus 로고    scopus 로고
    • Cannabis as a risk factor for psychosis: Systematic review
    • Semple DM, McIntosh AM, Lawrie SM. Cannabis as a risk factor for psychosis: systematic review. J Psychopharmacol. 2005;19(2):187-194.
    • (2005) J Psychopharmacol , vol.19 , Issue.2 , pp. 187-194
    • Semple, D.M.1    McIntosh, A.M.2    Lawrie, S.M.3
  • 33
    • 28644440381 scopus 로고    scopus 로고
    • Cannabis-induced psychosis and subsequent schizophrenia spectrum disorders: Follow-up study of 535 incident cases
    • Arendt M, Rosenberg R, Foldager L, Perto G, Munk-Jorgensen P. Cannabis-induced psychosis and subsequent schizophrenia spectrum disorders: follow-up study of 535 incident cases. Br J Psychiatry. 2005;187:510-515.
    • (2005) Br J Psychiatry , vol.187 , pp. 510-515
    • Arendt, M.1    Rosenberg, R.2    Foldager, L.3    Perto, G.4    Munk-Jorgensen, P.5
  • 35
    • 55749104091 scopus 로고    scopus 로고
    • Familial predisposition for psychiatric disorder: Comparison of subjects treated for cannabis-induced psychosis and schizophrenia
    • Arendt M, Mortensen PB, Rosenberg R, Pedersen CB, Waltoft BL. Familial predisposition for psychiatric disorder: comparison of subjects treated for cannabis-induced psychosis and schizophrenia. Arch Gen Psychiatry. 2008;65(11):1269-1274.
    • (2008) Arch Gen Psychiatry , vol.65 , Issue.11 , pp. 1269-1274
    • Arendt, M.1    Mortensen, P.B.2    Rosenberg, R.3    Pedersen, C.B.4    Waltoft, B.L.5
  • 36
    • 56049094316 scopus 로고    scopus 로고
    • Temporal association of cannabis use with symptoms in individuals at clinical high risk for psychosis
    • Corcoran CM, Kimhy D, Stanford A, et al. Temporal association of cannabis use with symptoms in individuals at clinical high risk for psychosis. Schizophr Res. 2008;106(2-3):286-293.
    • (2008) Schizophr Res , vol.106 , Issue.2-3 , pp. 286-293
    • Corcoran, C.M.1    Kimhy, D.2    Stanford, A.3
  • 37
    • 20944446077 scopus 로고    scopus 로고
    • Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: Longitudinal evidence of a gene x environment interaction
    • Caspi A, Moffitt TE, Cannon M, et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene x environment interaction. Biol Psychiatry. 2005;57(10):1117-1127.
    • (2005) Biol Psychiatry , vol.57 , Issue.10 , pp. 1117-1127
    • Caspi, A.1    Moffitt, T.E.2    Cannon, M.3
  • 38
    • 67649445894 scopus 로고    scopus 로고
    • Evidence for association between polymorphisms in the cannabinoid receptor 1 (CNR1) gene and cannabis dependence
    • Nov 14 [epub ahead of print
    • Agrawal A, Wetherill L, Dick DM, et al. Evidence for association between polymorphisms in the cannabinoid receptor 1 (CNR1) gene and cannabis dependence. Am J Med Genet B Neuropsychiatr Genet. 2008 Nov 14 [epub ahead of print].
    • (2008) Am J Med Genet B Neuropsychiatr Genet
    • Agrawal, A.1    Wetherill, L.2    Dick, D.M.3
  • 41
    • 8444242207 scopus 로고    scopus 로고
    • Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms
    • Giuffrida A, Leweke FM, Gerth CW, et al. Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms. Neuropsychopharmacology. 2004;29(11):2108-2114.
    • (2004) Neuropsychopharmacology , vol.29 , Issue.11 , pp. 2108-2114
    • Giuffrida, A.1    Leweke, F.M.2    Gerth, C.W.3
  • 42
    • 49149114972 scopus 로고    scopus 로고
    • Prospective association between cannabis use, abuse, and dependence and panic attacks and disorder
    • Zvolensky MJ, Lewinsohn, P, Bernstein A, et al. Prospective association between cannabis use, abuse, and dependence and panic attacks and disorder. J Psychiatr Res. 2008;42(12):1017-1023.
    • (2008) J Psychiatr Res , vol.42 , Issue.12 , pp. 1017-1023
    • Zvolensky, M.J.1    Lewinsohn, P.2    Bernstein, A.3
  • 43
    • 0029809662 scopus 로고    scopus 로고
    • Medication noncompliance and substance abuse among patients with schizophrenia
    • Owen RR, Fischer EP, Booth BM, Cuffel BJ. Medication noncompliance and substance abuse among patients with schizophrenia. Psychiatr Serv. 1996;47(8):853-858.
    • (1996) Psychiatr Serv , vol.47 , Issue.8 , pp. 853-858
    • Owen, R.R.1    Fischer, E.P.2    Booth, B.M.3    Cuffel, B.J.4
  • 44
    • 33645104040 scopus 로고    scopus 로고
    • Substance use in persons with schizophrenia: Baseline prevalence and correlates from the NIMH CATIE study
    • Swartz MS, Wagner HR, Swanson JW, et al. Substance use in persons with schizophrenia: baseline prevalence and correlates from the NIMH CATIE study. J Nerv Mental Dis. 2006;194(3):164-172.
    • (2006) J Nerv Mental Dis , vol.194 , Issue.3 , pp. 164-172
    • Swartz, M.S.1    Wagner, H.R.2    Swanson, J.W.3
  • 45
    • 0026234817 scopus 로고
    • Co-occurring disorders among mentally ill jail detainees. Implications for public policy
    • Abram KM, Teplin LA. Co-occurring disorders among mentally ill jail detainees. Implications for public policy. Am Psychol. 1991;46(10):1036-1045.
    • (1991) Am Psychol , vol.46 , Issue.10 , pp. 1036-1045
    • Abram, K.M.1    Teplin, L.A.2
  • 46
    • 0035672215 scopus 로고    scopus 로고
    • Recent victimization in women and men with severe mental illness: Prevalence and correlates
    • Goodman LA, Salyers MP, Mueser KT, et al. Recent victimization in women and men with severe mental illness: prevalence and correlates. J Trauma Stress. 2001;14(4):615-632.
    • (2001) J Trauma Stress , vol.14 , Issue.4 , pp. 615-632
    • Goodman, L.A.1    Salyers, M.P.2    Mueser, K.T.3
  • 47
    • 2942623635 scopus 로고    scopus 로고
    • A review of treatments for people with severe mental illness and co-occurring substance use disorders
    • Drake RE, Mueser KT, Brunette MF, McHugo GJ. A review of treatments for people with severe mental illness and co-occurring substance use disorders. Psychiatr Rehabil J. 2004;27(4):360-374.
    • (2004) Psychiatr Rehabil J , vol.27 , Issue.4 , pp. 360-374
    • Drake, R.E.1    Mueser, K.T.2    Brunette, M.F.3    McHugo, G.J.4
  • 48
    • 0038054642 scopus 로고    scopus 로고
    • Clozapine, quetiapine, and olanzepine among addicted schizophrenic patients: Towards testable hypotheses
    • Potvin S, Stip E, Roy JY. Clozapine, quetiapine, and olanzepine among addicted schizophrenic patients: towards testable hypotheses. Int Clin Psychopharmacol. 2003;18(3):121-132.
    • (2003) Int Clin Psychopharmacol , vol.18 , Issue.3 , pp. 121-132
    • Potvin, S.1    Stip, E.2    Roy, J.Y.3
  • 50
    • 33645513262 scopus 로고    scopus 로고
    • A randomized clinical trial of a new behavioral treatment for drug abuse with people with severe and persistent mental illness
    • Bellack AS, Bennett ME, Gearon JS, Brown CH, Yang Y. A randomized clinical trial of a new behavioral treatment for drug abuse with people with severe and persistent mental illness. Arch Gen Psychiatry. 2006;63(4):426-432.
    • (2006) Arch Gen Psychiatry , vol.63 , Issue.4 , pp. 426-432
    • Bellack, A.S.1    Bennett, M.E.2    Gearon, J.S.3    Brown, C.H.4    Yang, Y.5
  • 51
    • 33846511806 scopus 로고    scopus 로고
    • A randomized trial of integrated group therapy versus group drug counseling for patients with bipolar disorder and substance dependence
    • Weiss RD, Griffin ML, Kolodziej ME, et al. A randomized trial of integrated group therapy versus group drug counseling for patients with bipolar disorder and substance dependence. Am J Psychiatry. 2007;164(1):100-1007.
    • (2007) Am J Psychiatry , vol.164 , Issue.1 , pp. 100-1007
    • Weiss, R.D.1    Griffin, M.L.2    Kolodziej, M.E.3
  • 52
    • 33644825837 scopus 로고    scopus 로고
    • The impact of enhanced incentives on vocational rehabilitation outcomes in dually diagnosed veterans
    • Drebing CE, Van Ormer EA, Krebs C, et al. The impact of enhanced incentives on vocational rehabilitation outcomes in dually diagnosed veterans. J Appl Behav Anal. 2005;38(3):359-372.
    • (2005) J Appl Behav Anal , vol.38 , Issue.3 , pp. 359-372
    • Drebing, C.E.1    Van Ormer, E.A.2    Krebs, C.3
  • 53
    • 9144233382 scopus 로고    scopus 로고
    • A review of research on residential programs for people with severe mental illness and co-occurring substance use disorders
    • Brunette MF, Mueser KT, Drake RE. A review of research on residential programs for people with severe mental illness and co-occurring substance use disorders. Drug Alcohol Rev. 2004;23(4):471-481.
    • (2004) Drug Alcohol Rev , vol.23 , Issue.4 , pp. 471-481
    • Brunette, M.F.1    Mueser, K.T.2    Drake, R.E.3
  • 54
    • 53949091860 scopus 로고    scopus 로고
    • Blockade of THC-seeking behavior and relapse in monkeys by the cannabin oid CB(1)-receptor antagonist rimonabant
    • Justinova Z, Munzar P, Panlilio LV, et al. Blockade of THC-seeking behavior and relapse in monkeys by the cannabin oid CB(1)-receptor antagonist rimonabant. Neuropsychopharmacology. 2008;33(12):2870-2877.
    • (2008) Neuropsychopharmacology , vol.33 , Issue.12 , pp. 2870-2877
    • Justinova, Z.1    Munzar, P.2    Panlilio, L.V.3
  • 55
    • 34249046462 scopus 로고    scopus 로고
    • Opioid antagonism of cannabinoid effects: Differences between marijuana smokers and nonmarijuana smokers
    • Haney M. Opioid antagonism of cannabinoid effects: differences between marijuana smokers and nonmarijuana smokers. Neuropsychopharmacology. 2007;32(6):1391-1403.
    • (2007) Neuropsychopharmacology , vol.32 , Issue.6 , pp. 1391-1403
    • Haney, M.1
  • 56
    • 58149354259 scopus 로고    scopus 로고
    • Marijuana neurobiology and treatment
    • Elkashef A, Vocci F, Huestis M, et al. Marijuana neurobiology and treatment. Subst Abus. 2008;29(3):17-29.
    • (2008) Subst Abus , vol.29 , Issue.3 , pp. 17-29
    • Elkashef, A.1    Vocci, F.2    Huestis, M.3
  • 58
    • 0028836313 scopus 로고    scopus 로고
    • Svensson TH, Mathé JM, Andersson JL, Nomikos GG, Hildebrand BE, Marcus M. Mode of action of atypical neuroleptic in relation to the phencyclidine model of schizophrenia: role of 5-HT2 receptor and alpha-1 adrenoreceptor antagonism. J Clin Psychopharmacol. 2005;15(1 suppl 1):11S-18S. Erratum in: J Clin Psychopharmacol. 1995;15(2):154.
    • Svensson TH, Mathé JM, Andersson JL, Nomikos GG, Hildebrand BE, Marcus M. Mode of action of atypical neuroleptic in relation to the phencyclidine model of schizophrenia: role of 5-HT2 receptor and alpha-1 adrenoreceptor antagonism. J Clin Psychopharmacol. 2005;15(1 suppl 1):11S-18S. Erratum in: J Clin Psychopharmacol. 1995;15(2):154.
  • 59
    • 76749125195 scopus 로고    scopus 로고
    • Pharmacological treatment of substance abuse disorders
    • eds, 3rd ed. West Sussex, UK: Wiley-Blackwell;
    • Raby WN, Levin, FR, Nunes EV. Pharmacological treatment of substance abuse disorders. In: Tasman A, Kay J, Lieberman JA, First MB, Maj M, eds. Psychiatry. 3rd ed. West Sussex, UK: Wiley-Blackwell; 2008:2390-2412.
    • (2008) Psychiatry , pp. 2390-2412
    • Raby, W.N.1    Levin, F.R.2    Nunes, E.V.3
  • 60
    • 0033002549 scopus 로고    scopus 로고
    • Clozapine for co morbid substance use disorder and schizophrenia: Do patients with schizophrenia have a reward-deficiency syndrome that can be ameliorated by clozapine?
    • Green AI, Zimmet SV, Strous RD, Schildkraut JJ. Clozapine for co morbid substance use disorder and schizophrenia: Do patients with schizophrenia have a reward-deficiency syndrome that can be ameliorated by clozapine? Harvard Rev Psychiatry. 1999;6(6):287-296.
    • (1999) Harvard Rev Psychiatry , vol.6 , Issue.6 , pp. 287-296
    • Green, A.I.1    Zimmet, S.V.2    Strous, R.D.3    Schildkraut, J.J.4
  • 61
    • 24944509682 scopus 로고    scopus 로고
    • Treatment of substance use disorders in schizophrenia: A unifying neurobiological mechanism?
    • Roth RM, Brunette MF, Green AI. Treatment of substance use disorders in schizophrenia: a unifying neurobiological mechanism? Curr Psychiatry Rep. 2005;7(4):283-291.
    • (2005) Curr Psychiatry Rep , vol.7 , Issue.4 , pp. 283-291
    • Roth, R.M.1    Brunette, M.F.2    Green, A.I.3
  • 62
    • 0028214584 scopus 로고
    • Substance abuse among patients with treatment-resistant schizophrenia: Characteristics and implications for clozapine therapy
    • Buckley P, Thompson P, Way L, Meltzer HY. Substance abuse among patients with treatment-resistant schizophrenia: characteristics and implications for clozapine therapy. Am J Psychiatry. 1994;151(3):385-389.
    • (1994) Am J Psychiatry , vol.151 , Issue.3 , pp. 385-389
    • Buckley, P.1    Thompson, P.2    Way, L.3    Meltzer, H.Y.4
  • 63
    • 0033918990 scopus 로고    scopus 로고
    • The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia
    • Drake RE, Xie H, McHugo GJ, Green AI. The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia. Schizophr Bull. 2000;26(2):441-449.
    • (2000) Schizophr Bull , vol.26 , Issue.2 , pp. 441-449
    • Drake, R.E.1    Xie, H.2    McHugo, G.J.3    Green, A.I.4
  • 64
    • 33748800996 scopus 로고    scopus 로고
    • Clozapine use and relapses of substance use disorder among patients with co-occurring schizophrenia and substance use disorders
    • Brunette M, Drake RE, Xie H, McHugo GJ, Green AI. Clozapine use and relapses of substance use disorder among patients with co-occurring schizophrenia and substance use disorders. Schizophr Bull. 2006;32(4):637-643.
    • (2006) Schizophr Bull , vol.32 , Issue.4 , pp. 637-643
    • Brunette, M.1    Drake, R.E.2    Xie, H.3    McHugo, G.J.4    Green, A.I.5
  • 65
    • 36749055662 scopus 로고    scopus 로고
    • Substance abuse and schizophrenia: Pharmacotherapeutic interventions
    • Green AI, Noordsy DL, Brunette MF, O'Keefe C. Substance abuse and schizophrenia: pharmacotherapeutic interventions. J Subst Abuse Treat. 2008;34(1):61-71.
    • (2008) J Subst Abuse Treat , vol.34 , Issue.1 , pp. 61-71
    • Green, A.I.1    Noordsy, D.L.2    Brunette, M.F.3    O'Keefe, C.4
  • 66
    • 45349104422 scopus 로고    scopus 로고
    • Cannabis as a risk factor for psychosis in vulnerable teens: Implications for treatment
    • Bodkin LL, Singh A, Corcoran C. Cannabis as a risk factor for psychosis in vulnerable teens: implications for treatment. Primary Psychiatry. 2008;15(1):51-57.
    • (2008) Primary Psychiatry , vol.15 , Issue.1 , pp. 51-57
    • Bodkin, L.L.1    Singh, A.2    Corcoran, C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.